1-4 of 4
Dirk Zboralski, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Ibrutinib, Idelalisib and Olaptesed Pegol on the Immune Effector Function Mediated By Rituximab

Dirk Zboralski, PhD, Axel Vater, PhD, Anna Kruschinski, PhD
Journal: Blood
Blood (2014) 124 (21): 4499.
https://doi.org/10.1182/blood.V124.21.4499.4499
Published: 2014
Journal Articles

Mode of Action of the SDF-1/CXCL12 Inhibiting Spiegelmer ® Nox-A12 and Its Impact On Chronic Lymphocytic Leukemia (CLL) Cell Motility and Chemosensitization

Dirk Zboralski, PhD, Julia Hoellenriegel, Christian Maasch, PhD, Anna Kruschinski, PhD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 318.
https://doi.org/10.1182/blood.V120.21.318.318
Published: 2012
Journal Articles

In Vivo Targeting of Stromal-Derived Factor-1 As a Strategy to Prevent Myeloma Cell Dissemination to Distant Bone Marrow Niches

Aldo M. Roccaro, MD, PhD, Antonio Sacco, BS, Marco Ungari, MD, Patricia Maiso, PhD, Salomon Manier, MD, Phong Quang, BS, Yosra Aljaway, BS, Dirk Zboralski, PhD, Anna Kruschinski, PhD, Fabio Facchetti, MD, Giuseppe Rossi, MD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2012) 120 (21): 440.
https://doi.org/10.1182/blood.V120.21.440.440
Published: 2012
Journal Articles

The Spiegelmer Nox-A12, a Novel SDF-1 (CXCL12) Inhibitor, and Its Effects on Chronic Lymphocytic Leukemia (CLL) Cell Migration,

Julia Hoellenriegel, Dirk Zboralski, PhD, Zeev Estrov, William G. Wierda, MD, PhD, Michael Keating, MD, Anna Kruschinski, PhD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3878.
https://doi.org/10.1182/blood.V118.21.3878.3878
Published: 2011